Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
62.58
+0.94 (1.52%)
At close: Feb 9, 2026, 4:00 PM EST
62.39
-0.19 (-0.30%)
After-hours: Feb 9, 2026, 4:49 PM EST

Utah Medical Products Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
199179208306365365
Market Cap Growth
-6.30%-14.01%-31.80%-16.18%-0.11%18.97%
Enterprise Value
11395120218296301
Last Close Price
61.6455.9660.1880.9895.3993.64
PE Ratio
17.7015.8915.0318.3822.1424.69
Forward PE
-17.8017.8017.8017.8017.80
PS Ratio
5.184.655.106.096.987.44
PB Ratio
1.651.501.782.383.193.41
P/TBV Ratio
1.901.722.072.794.034.85
P/FCF Ratio
--14.2814.1217.9317.68
P/OCF Ratio
--14.0613.7217.2517.22
PEG Ratio
-1.191.191.191.191.19
EV/Sales Ratio
2.942.472.944.345.656.14
EV/EBITDA Ratio
7.906.646.498.8011.0211.51
EV/EBIT Ratio
9.948.357.6511.8114.9315.95
EV/FCF Ratio
--8.2410.0614.5314.58
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.020.020.020.010.010.02
Debt / FCF Ratio
--0.020.010.020.02
Asset Turnover
0.310.310.320.390.440.43
Inventory Turnover
1.971.971.822.192.612.83
Quick Ratio
34.3634.3623.1820.4413.5217.65
Current Ratio
37.6237.6225.6422.5615.0919.54
Return on Equity (ROE)
9.54%9.54%11.29%13.72%14.88%14.09%
Return on Assets (ROA)
5.82%5.82%7.62%8.89%10.33%10.38%
Return on Invested Capital (ROIC)
26.84%26.62%36.84%40.56%36.65%29.85%
Return on Capital Employed (ROCE)
9.50%9.50%13.20%14.10%16.80%16.90%
Earnings Yield
5.68%6.30%6.65%5.44%4.52%4.05%
FCF Yield
--7.00%7.08%5.58%5.66%
Dividend Yield
1.98%2.19%2.00%1.46%1.22%0.91%
Payout Ratio
35.31%-30.70%25.74%19.20%77.53%
Buyback Yield / Dilution
7.51%7.51%3.68%0.16%0.46%0.33%
Total Shareholder Return
9.51%9.70%5.68%1.63%1.69%1.24%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q